icon-folder.gif   Conference Reports for NATAP  
 
  DDW 2009
May 30 - June 4, 2009
McCormick Place: Chicago, Illinois
Back grey_arrow_rt.gif
 
 
 
Long-Term Histological Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs
 
 
  Reported by Jules Levin
DDW Chicago May 30-June 4 2009
 
YF Liaw1, TT Chang2, SS Wu3, ER Schiff4, KH Han5, CL Lai6, R Safadi7, SS Lee8, W Halota9, ZD Goodman10, H Zhang11, U Iloeje11, S Beebe11, B Kreter12, H Ishikawa13, Y Katano14, K Takaguchi15, M Omata16 1. Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan. 2. National Cheng Kung University Medical College, Tainan, Taiwan. 3. Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan. 4. University of Miami Hospital & Clinics, Miami, FL, USA. 5. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. 6. Department of Medicine, Queen Mary's Hospital, University of Hong Kong, Hong Kong, China. 7. Division of Medicine, Hadassah Medical Center, Jerusalem, Israel. 8. Liver Unit, University of Calgary, Calgary, AB, Canada. 9. Klinika Chorob Zakaznych AM, Bydgoszcz, Poland. 10. Armed Forces Institute of Pathology, Washington, WA, USA. 11. Research & Development, Bristol-Myers Squibb Company, Wallingford, CT, USA. 12. Research & Development, Bristol-Myers Squibb Company, Princeton, NJ, USA. 13. Research & Development, Bristol-Myers KK, Tokyo, Japan. 14. Department of Gastroenterology, Graduate School of Medicine, Nagoya University, Aichi, Japan. 15.Department of Internal Medicine, Kagawa Prefectural Central Hospital, Kagawa, Japan. 16. Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo,

sumRestuls-1.gif

JapPR-2.gif

Intro-3.gif

Nucl-4.gif

Histo-5.gif

Ranke-6.gif

resist-7.gif

Cohort-8.gif

week-9.gif

Baseline-10.gif

bio-11.gif

knodell-12.gif

score-13.gif

Ishak-14.gif